Skip to main content

Retym

Retym is a software company that provides tools for generating and managing synthetic medical imaging datasets for Machine Learning (ML) and Artificial Intelligence (AI) development in healthcare.

  • Synthetic medical image generation for AI training and validation (healthcare AI data)
  • Configurable pipelines for creating labeled datasets from medical imaging modalities
  • Support for privacy-preserving workflows using synthetic rather than real patient data
  • Tooling targeted at computer vision and diagnostic model development teams
  • Services focused on healthcare providers, life sciences organizations, and medical AI startups

More About Retym

Retym focuses on synthetic data generation for medical imaging, serving healthcare and life sciences organizations that build and evaluate ML models. Its offering is positioned for teams that work with modalities such as X-ray, Current Transformer (CT), MRI, and other diagnostic imaging sources, and that need large volumes of labeled examples without direct reliance on identifiable patient records. The platform is relevant to data scientists, ML engineers, and clinical AI groups that require controlled variation, ground-truth labels, and reproducible data pipelines for computer vision workflows (AI/ML data management).

The company’s technology centers on programmatic generation of synthetic images that mimic the structure and statistical properties of real-world medical data while decoupling the output from individual patients. Retym’s workflows are intended to plug into common ML toolchains, enabling dataset creation for training, validation, and stress-testing of models in areas such as disease detection, triage support, or image enhancement. By using synthetic datasets, organizations can explore scenario coverage and edge cases that may be rare or underrepresented in clinical archives, while maintaining tighter control over data balance and label quality.

Retym’s platform can be placed in the broader category of synthetic data platforms for computer vision (synthetic data / computer vision). Within that category, it is differentiated by a focus on healthcare imaging use cases and the regulatory and privacy constraints that apply to hospitals, research institutions, and medical AI vendors. The workflows are suited to environments where PHI compliance, data-sharing restrictions, and cross-border data transfer rules affect access to real images. Synthetic data generated by the system can be used to augment limited real datasets, support benchmarking of models from multiple vendors, or facilitate internal experimentation where direct access to clinical archives is constrained.

From an architectural perspective, Retym’s tools are built for integration into existing Machine Learning Operations (MLOps) and data engineering stacks. Generated datasets can be exported into standard formats used by computer vision libraries and frameworks (AI/ML infrastructure), supporting downstream use with common training pipelines. Technical teams can incorporate Retym into data preparation stages, combine synthetic and real-world samples, and iterate on dataset parameters as model requirements evolve. For enterprise directories and marketplaces, Retym best fits into categories such as synthetic data for healthcare, medical imaging AI tooling, and ML data preparation services.

At-A-Glance

  • Employees: 5
  • Estimated Annual Revenue: $0-$1M

Connect

Corporate Headquarters

20380 Town Center Lane
218
Cupertino, CA 95014

Market Segmentation

  • Type: Private
  • Sector: Information Technology
  • Group: Semiconductors & Semiconductor Equipment
  • Industry: Semiconductors & Semiconductor Equipment
  • Sub-Industry: Semiconductors